#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Netherton's syndrome Acute lymphocytic leukaemia Hidradenitis Fibrosarcoma Marginal zone lymphoma Oropharyngeal squamous cell carcinoma Chronic kidney disease Carcinoid tumour Synovial sarcoma Retinopathy proliferative Duchenne muscular dystrophy Malignant melanoma Atypical haemolytic uraemic syndrome Philadelphia positive acute lymphocytic leukaemia Methylmalonic acidaemia More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Diagnostics Brain stem glioma – Life with Disease Amyotrophic lateral sclerosis – Basic Information Cholangitis sclerosing Rhabdoid tumour – Basic Information IgA nephropathy – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Encephalitis autoimmune – Diagnostics Acquired haemophilia Ewing’s sarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pegaspargase Omp64 RO7284755 Doxycycline Monohydrate Spesolimab Folinic Acid Annamycin Azd0901 F44/10 DESMOPRESSIN ACETATE Idarubicin Hydrochloride Apitegromab Corylus Avellana L. Danicopan Aprepitant DISODIUM PHOSPHATE MAGNESIUM ACETATE TETRAHYDRATE Namilumab USNOFLAST L-PHENYLALANINE More therapies…

    Learn about Your Condition

    Kidney transplant rejection Wolfram syndrome Osteoporosis postmenopausal Carotid artery occlusion Inflammatory bowel disease Lichenoid keratosis Pre-eclampsia Noninfective chorioretinitis Klinefelter's syndrome Parkinson's disease Leber's congenital amaurosis Mucopolysaccharidosis II Melanoma recurrent Mucopolysaccharidosis Death neonatal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colorectal adenocarcinoma

  • Study on Atezolizumab for Patients with High-Risk Stage II or Stage III Colorectal Cancer Not Eligible for Oxaliplatin Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    • Colon cancer stage III
    • Colorectal adenocarcinoma
    Investigated Drugs:
    • Atezolizumab
    • Mycobaterium Obuense, Strain Nctc 13365, Heat-Killed
    Germany

  • Study on the Effectiveness of FOLFOX and Panitumumab for Patients with Metastatic Colorectal Cancer Without RAS Mutation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal adenocarcinoma
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    Belgium France

  • Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer metastatic
    • Head and neck cancer stage III
    • Head and neck cancer stage IV
    Investigated Drugs:
    • Tisotumab Vedotin
    • Carboplatin
    • Cisplatin
    France Germany Italy Spain

  • Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    • Colorectal adenocarcinoma
    • Colorectal cancer
    Investigated Drugs:
    • Incb099280
    • Ipilimumab
    Norway Slovakia Sweden

  • Study on Encorafenib, Cetuximab, and FOLFIRI for Patients with BRAF V600E Mutated Metastatic Colorectal Cancer After Progression on Encorafenib and Cetuximab

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal adenocarcinoma
    Investigated Drugs:
    • Cetuximab
    • Encorafenib
    • Fluorouracil
    Italy

  • Study on the Effectiveness and Safety of Cetuximab, Encorafenib, and Binimetinib for Patients with Advanced Colorectal Cancer with BRAF V600E Mutation

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Binimetinib
    • Cetuximab
    • Encorafenib
    Spain
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!